Showcases Multiple Forward-Looking Radiotherapy Solutions Designed to Enhance the Treatment Experience for Medical Care Teams and Their Patients SUNNYVALE, Calif. , Oct. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for
SUNNYVALE, Calif. , Oct. 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021 , after the market close on Wednesday, November 3, 2021 . Management will host a conference call to review the
Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.